A retrospective cohort study evaluated the Nursing Science Precision Health model for pain management in 287 rheumatoid arthritis patients categorized by pain phenotype (inflammatory, non-inflammatory, or mixed). Over 12 weeks, patients received phenotype-specific interventions: pharmacological treatment for inflammatory pain, psychological counseling and mindfulness for non-inflammatory pain, or combined therapies for mixed pain. No comparator group was reported.
The study reported significant improvements in pain outcomes across all phenotypes, though specific effect sizes, absolute numbers, and statistical measures were not provided. For inflammatory pain patients, reductions in CRP, ESR, and VAS pain scores were observed. For non-inflammatory pain patients, reductions in anxiety, depression, and VAS scores, plus improvements in sleep quality, were reported. Patient-reported quality of life and functional status also improved significantly, and 82.6% of patients expressed satisfaction with their pain management plan.
Safety and tolerability data were not reported. Key limitations include the retrospective design, absence of a control group, and lack of reported effect sizes and statistical measures. The findings suggest an association between phenotype-based management and improved outcomes, but the retrospective, uncontrolled nature prevents causal inference. This model may offer a framework for personalized care, but its effectiveness relative to standard approaches remains unestablished.
View Original Abstract ↓
IntroductionRheumatoid arthritis (RA) is a chronic inflammatory disease characterized by pain, functional disability, and comorbidities. Pain management in RA is complex due to both inflammatory and non-inflammatory mechanisms. The Nursing Science Precision Health (NSPH) model offers a personalized approach to pain management, integrating symptom measurement, phenotypic analysis, and biomarker data to guide tailored interventions.MethodsThe recorded data of 287 RA patients were retrospectively archived and categorized into three pain phenotypes: inflammatory pain, non-inflammatory pain, and mixed pain. Pain was assessed using the Visual Analog Scale (VAS), and biomarkers were measured at baseline. Psychological factors, including anxiety, depression, and sleep quality, were also evaluated. Patients’ phenotype-specific interventions were extracted from clinical records: pharmacological treatment for inflammatory pain, psychological counseling and mindfulness-based stress reduction for non-inflammatory pain, and combined therapies for mixed pain. Follow-up assessments were conducted at 12 weeks.ResultsSignificant improvements were observed across all pain phenotypes. Inflammatory pain patients showed reductions in CRP, ESR, and VAS pain scores. Non-inflammatory pain patients experienced reductions in anxiety, depression, and VAS scores, with improvements in sleep quality. Mixed pain patients benefited from both pharmacological and psychological interventions. Patient-reported outcomes, including quality of life and functional status, improved significantly, with 82.6% expressing satisfaction with their pain management plan.DiscussionThe NSPH model offers an effective framework for personalized RA pain management, demonstrating that phenotype-based interventions improve pain outcomes, reduce psychosocial distress, and enhance quality of life. This approach holds potential for broader application in chronic pain management and warrants further research to optimize its implementation.